ClinicalTrials.Veeva

Menu

Attachment and Prognostic Factor: the Implicit Approach (AIA)

C

Centre Hospitalier Henri Laborit

Status

Begins enrollment in 6 months

Conditions

Dependence Addictive

Treatments

Behavioral: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT04954027
2021-A00432-39

Details and patient eligibility

About

This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence.

5 visits are planned during the study :

  • the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
  • 4 telephone interviews for follow-up by investigator.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients between 18 and 65 years old
  • Patients with a use-related disorder as defined by DSM5
  • Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
  • Having expressed non-opposition to participating in the study after receiving written information.

Exclusion criteria

  • Person who cannot read or write
  • Simultaneous participation in a therapeutic trial involving oxytocin
  • Patients protected by law
  • Patients who do not have French as their native language
  • Patients who, in the opinion of the investigator, are unable to complete the questionnaires

Trial design

200 participants in 1 patient group

Patients with a use-related disorder weaning for a substance
Treatment:
Behavioral: Questionnaires

Trial contacts and locations

0

Loading...

Central trial contact

Wilfried SERRA, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems